Pre-market development times for biologic versus small-molecule drugs

Reed F Beall^{1

2}, Thomas J Hwang³, Aaron S Kesselheim³

Affiliations

¹ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. reed.beall@ucalgary.ca.
² Cummings School of Medicine and O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada. reed.beall@ucalgary.ca.
³ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Reed F Beall et al. Nat Biotechnol. 2019 Jul.

. 2019 Jul;37(7):708-711.

doi: 10.1038/s41587-019-0175-2.

Reed F Beall^{1

2}, Thomas J Hwang³, Aaron S Kesselheim³

¹ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. reed.beall@ucalgary.ca.
² Cummings School of Medicine and O'Brien Institute of Public Health, University of Calgary, Calgary, Alberta, Canada. reed.beall@ucalgary.ca.
³ Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

No abstract available

References

1. Mossinghoff, G. J. Food Drug Law J. 54, 187–194 (1999). - PubMed
1. Dunn, M. K. Nat. Rev. Drug Discov. 10, 487–488 (2011). - DOI
1. Pew Charitable Trusts. Policy proposal: reducing the exclusivity period for biological products. https://www.pewtrusts.org/-/media/assets/2017/09/dsri_policy_proposal_re... (2017).
1. Husser, A. Will USMCA affect Canada’s drug prices? Depends on what happens next, experts say. https://www.cbc.ca/news/health/usmca-pharma-drugs-prices-cost-1.4846421 (2018).
1. PhRMA. Response to request for comments on negotiating objectives for a U.S.–Japan trade agreement, 83 Fed. Reg. 54,164 (October 26, 2018). http://phrma-docs.phrma.org/files/dmfile/PhRMA-Comments-on-Negotiating-O... (2018).